Globalisation

B-I says Chinese JV Could Elevate Domestic Manufacturing Industry

10-Jun-2013 - Boehringer Ingelheim will build a biomanufacturing facility in Shanghai in a strategic alliance designed to cater for Pharmas nervous about setting up plants in China.

Pfizer Puts Lipitor Site Up For Sale as Patent Expiration Causes Over-Capacity

16-May-2013 - Lower sales of off-patent former blockbuster Lipitor have prompted Pfizer to try and sell off its third Irish API plant in as many years. 

Another US Plant Closure in Cost-Saving Plan as Teva Eyes Head 'East'

07-May-2013 - Teva will close a second US plant and shift manufacture to more cost effective facilities as part of its company-wide restructuring programme.

GMP Plants and BioPharma Clusters Drive Russia's Pharma 2020

30-Apr-2013 - International GMP standard facilities and six biopharma centres will lead Russia’s initiative in implementing its Pharma 2020 policy, according to statements at this year’s BIO International Convention.

DSM Opens Australian Government Backed Biologics Facility

24-Apr-2013 - With backing from the Australian Government, DSM has opened a mammalian cell culture operation to fuel the growing demand in the Asia-Pacific biologics market.

update

Sanofi Starts Semisynthetic Malaria Drug Production

17-Apr-2013 - Sanofi has started making artemisinin using a novel semisynthetic method it says will strengthen the global supplies of malaria drugs.

MSD Pushes Emerging Market Strategy With New China Packaging Facility

17-Apr-2013 - Merck & Co. has opened a new packaging facility in China to support its emerging market strategy but says it is still committed to traditional regions.

GE and iBio Confirm Fiocruz Vaccine Plant Project and Predict Future Collaborations

11-Apr-2013 - GE Healthcare and iBio are in talks about future projects after confirming they are working on a plant-based vaccine manufacturing site for Brazilian drugmaker Fiocruz/Bio-Manguinhosin.

New Vietnam Plant as Sanofi Leads the Way in Emerging Markets

03-Apr-2013 - Sanofi says it is “the leading healthcare company in emerging markets” as it invests $75m in a new manufacturing facility in Vietnam.

GSK Developing Low-Cost Polio Vax Manufacturing Tech with NIBSC

26-Mar-2013 - GSK is working on a low-cost manufacturing platform it will use to produce inactivated polio vaccines (IPV) for developing countries.

South Korean OK for BASF's Scottish Omega-3 plant

12-Mar-2013 - South Korean regulators have cleared BASF to produce pharmaceutical grade omega-3 at its facility in Scotland.

EC says Drugmakers Have Time to Mark Risky Drugs with Black Triangle

11-Mar-2013 - The European Commission (EC) says timelines for new laws requiring that risky drugs are marked for extra safety monitoring take industry practicalities into account.

Merck Serono: Fresh Pipeline Leads Growth but More Jobs Cuts to Come

07-Mar-2013 - Merck Serono says “fast progress” in its restructure programme helped double its net savings guidance for 2012 though headcount dropped by almost 2,000 with more cuts to come. 

Inspections Can't Solve Import-Related API Shortage Concerns says MHRA

05-Mar-2013 - Inspections in countries not expected to confirm API quality or seek exemption from new EU import regs “cannot be seen as a solution” to shortage concerns says the MHRA.

South Africa & Lonza Venture Hits Delay on API Facility Construction

27-Feb-2013 - A South African and Lonza joint project says issues in funding, competitiveness and green technologies have delayed construction of its API plant.

Oral Dose Competition Intensifies as Qualicaps Expands Manufacturing

26-Feb-2013 - Following a bout of investments, the oral dose solution market has been described as “competitive” and “dynamic” by two of the major players.

DSM says generics-focused partnering will drive pharma growth

20-Feb-2013 - Royal DSM expects its pharma unit to perform better in 2013 driven by a generics and end-of-lifecycle drug-focused partnership strategy. 

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

20-Feb-2013 - New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.

IMCD Buys Indian Distributor Indchem for Pharma business

20-Feb-2013 - Chemical distributor IMCD Group says acquisition of Mumbai-based Indchem will build its presence in the Indian pharmaceutical sxcipient sector.

AMRI Deal a Catalyst for Pharma Growth says Codexis

14-Feb-2013 - AMRI has teamed up with biocatalysis firm Codexis to develop cheaper, faster and greener ways of manufacturing APIs.

Beximco starts shipping Formulations to Europe

12-Feb-2013 - Formulations of two ophthalmic drugs have become the first exports to Europe from Bangladeshi company Beximco as they seek to expand into the EU market.

update

Denmark asks API users to register; EU sets out GMP assessment criteria

29-Jan-2013 - Danish companies that make, use, distribute or import APIs will need to register by March 1 or cease operations according to the Danish Health and Medicines Authority (DKMA).

SFDA asks API makers for GMP certificates ahead of new EU import laws

24-Jan-2013 - Chinese API makers will have to tell the SFDA if they have a European GMP certificate as part of a wider industry investigation prompted by new EU import laws.

SFDA ups rewards for people who shop illegal drugmakers

17-Jan-2013 - People who report illegal drug production could now earn up to 300,000 Yuan ($48,250) under a revised reward scheme launched by the SFDA.